EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteinuria in Immune-Mediated Glomerular Diseases as a Marker of Disease Activity and Therapeutic Response: A Retrospective Study

Miroslava Benkova-Petrova, Simona Bogdanova

Rheumatology (Bulgaria) · 19.03.2026 · 33 (4) · 28-45

DOI: 10.35465/gb6efc68 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology (Bulgaria), online erschienen am 19.03.2026. Verfasst von Miroslava Benkova-Petrova und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Proteinuria is an established marker of activity, severity, and progression in glomerular diseases. In addition to reflecting damage to the glomerular filtration barrier, it also plays a pathogenetic role in the development of tubulointerstitial inflammation and fibrosis.

Objectives

To assess the dynamics of proteinuria in patients with chronic glomerulonephritis and its significance as an indicator of therapeutic response.

Methods

A retrospective study of a total of 57 patients with different morphological forms of chronic glomerulonephritis, treated at the Clinic of Nephrology and Dialysis, St. Marina University Hospital – Varna, were followed for a period of 24 months. Twenty-four-hour proteinuria and the protein-to-creatinine ratio (Pr/Cr) in a spot urine sample were analyzed. All patients received optimal nephroprotective therapy, and immunosuppressive treatment was administered when indicated.

Results

The mean baseline 24-hour proteinuria was 5.94 g/24 h. By the third month, a statistically significant decrease to 3.65 g/24 h was observed (p≈0.008), followed by a further reduction to 2.7 g/24 h at month 6 and to 1.72 g/24 h at month 12. The observed reduction indicates an early and sustained therapeutic response in the studied patient population. Analysis of the protein-to-creatinine ratio confirmed the same favorable trend and supports its applicability as a reliable marker for monitoring proteinuria in clinical practice.

Conclusion

Early and sustained reduction of proteinuria is a reliable indicator of therapeutic efficacy in chronic glomerular diseases and is associated with a more favorable renal prognosis. Proteinuria has substantial value both as a prognostic marker and as a surrogate endpoint in clinical follow-up.

Zitieren

APA

Benkova-Petrova, M., & Bogdanova, S. (2026). Proteinuria in Immune-Mediated Glomerular Diseases as a Marker of Disease Activity and Therapeutic Response: A Retrospective Study. Rheumatology (Bulgaria), 33(4), 28-45. https://doi.org/10.35465/gb6efc68

Vancouver

Benkova-Petrova M, Bogdanova S. Proteinuria in Immune-Mediated Glomerular Diseases as a Marker of Disease Activity and Therapeutic Response: A Retrospective Study. Rheumatology (Bulgaria). 2026;33(4):28-45. doi:10.35465/gb6efc68

BibTeX
@article{BenkovaPetrova2026,
  author = {Benkova-Petrova, Miroslava and Bogdanova, Simona},
  title = {Proteinuria in Immune-Mediated Glomerular Diseases as a Marker of Disease Activity and Therapeutic Response: A Retrospective Study},
  journal = {Rheumatology (Bulgaria)},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {28--45},
  doi = {10.35465/gb6efc68}
}
Kostenlos starten →